4//SEC Filing
LARANJEIRA CHARLES ANTHONY 4
Accession 0001209191-20-039976
CIK 0001396814other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 9:17 PM ET
Size
25.0 KB
Accession
0001209191-20-039976
Insider Transaction Report
Form 4
LARANJEIRA CHARLES ANTHONY
SVP, Technical Operations
Transactions
- Sale
Common Stock
2020-06-29$50.01/sh−51,464$2,573,715→ 28,887 total - Sale
Common Stock
2020-06-29$51.77/sh−6,859$355,090→ 22,028 total - Exercise/Conversion
Common Stock
2020-06-29$37.81/sh+3,750$141,788→ 27,851 total - Exercise/Conversion
Common Stock
2020-06-29$43.54/sh+7,500$326,550→ 50,351 total - Exercise/Conversion
Common Stock
2020-06-29$44.10/sh+30,000$1,323,000→ 80,351 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-06-29−3,750→ 6,250 totalExercise: $37.81Exp: 2029-01-03→ Common Stock (3,750 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-06-29−15,000→ 15,000 totalExercise: $38.35Exp: 2028-06-13→ Common Stock (15,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-06-29−7,500→ 22,500 totalExercise: $43.54Exp: 2029-06-05→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2020-06-29$38.35/sh+15,000$575,250→ 42,851 total - Sale
Common Stock
2020-06-29$52.03/sh−1,778$92,509→ 20,250 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-06-29−30,000→ 10,000 totalExercise: $44.10Exp: 2027-06-02→ Common Stock (30,000 underlying)
Footnotes (6)
- [F1]The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.94, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.06 to $51.99, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.10, inclusive.
- [F5]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
- [F6]The stock option vests and becomes exercisable as to 25% of the option shares on May 1, 2018, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001524338
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 9:17 PM ET
- Size
- 25.0 KB